Literature DB >> 23526092

Alterations in K-ras, APC and p53-multiple genetic pathway in colorectal cancer among Indians.

Pooja Malhotra1, Mumtaz Anwar, Neha Nanda, Rakesh Kochhar, Jai Dev Wig, Kim Vaiphei, Safrun Mahmood.   

Abstract

The incidence of colorectal cancer (CRC) is increasing rapidly in Asian countries during the past few decades, but no comprehensive analysis has been done to find out the exact cause of this disease. In this study, we investigated the frequencies of mutations and expression pattern of K-ras, APC (adenomatosis polyposis coli) and p53 in tumor, adjoining and distant normal mucosa and to correlate these alterations with patients clinicopathological parameters as well as with the survival. Polymerase chain reaction (PCR)-restriction digestion was used to detect mutations in K-ras and PCR-SSCP (Single Strand Conformation Polymorphism) followed by DNA sequencing was used to detect mutations in APC and p53 genes. Immunohistochemistry was used to detect the expression pattern of K-ras, APC and p53 proteins. The frequencies of mutations of K-ras, APC and p53 in 30 tumor tissues samples were 26.7 %, 46.7 % and 20 %, respectively. Only 3.3 % of tumors contained mutations in all the three genes. The most common combination of mutation was APC and p53 whereas mutation in both p53 and K-ras were extremely rare. There was no association between the mutations and expression pattern of K-ras, APC and p53 (p>0.05). In Indians, the frequency of alterations of K-ras and APC is similar as in Westerns, whereas the frequency of p53 mutation is slightly lower. The lack of multiple mutations in tumor specimens suggests that these genetic alterations might have independent influences on CRC development and there could be multiple alternative genetic pathways to CRC in our present study cohort.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23526092     DOI: 10.1007/s13277-013-0734-y

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  58 in total

1.  Optimizing the APC gene mutation analysis in archival colorectal tumor tissue.

Authors:  J Poncin; J Mulkens; J W Arends; A de Goeij
Journal:  Diagn Mol Pathol       Date:  1999-03

2.  Cancer Incidence in Five Continents. Comparability and quality of data.

Authors:  D M Parkin; C S Muir
Journal:  IARC Sci Publ       Date:  1992

3.  Accumulation of beta-catenin protein and mutations in exon 3 of beta-catenin gene in gastrointestinal carcinoid tumor.

Authors:  M Fujimori; S Ikeda; Y Shimizu; M Okajima; T Asahara
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

4.  Localization of the gene for familial adenomatous polyposis on chromosome 5.

Authors:  W F Bodmer; C J Bailey; J Bodmer; H J Bussey; A Ellis; P Gorman; F C Lucibello; V A Murday; S H Rider; P Scambler
Journal:  Nature       Date:  1987 Aug 13-19       Impact factor: 49.962

5.  Prognostic significance of p53 mutations in colon cancer at the population level.

Authors:  Wade S Samowitz; Karen Curtin; Khe-ni Ma; Sandra Edwards; Donna Schaffer; Mark F Leppert; Martha L Slattery
Journal:  Int J Cancer       Date:  2002-06-01       Impact factor: 7.396

6.  p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.

Authors:  S J Baker; A C Preisinger; J M Jessup; C Paraskeva; S Markowitz; J K Willson; S Hamilton; B Vogelstein
Journal:  Cancer Res       Date:  1990-12-01       Impact factor: 12.701

7.  K-ras mutations and RASSF1A promoter methylation in colorectal cancer.

Authors:  Manon van Engeland; Guido M J M Roemen; Mirian Brink; Marco M M Pachen; Matty P Weijenberg; Adriaan P de Bruïne; Jan-Willem Arends; Piet A van den Brandt; Anton F P M de Goeij; James G Herman
Journal:  Oncogene       Date:  2002-05-23       Impact factor: 9.867

8.  APC mutations occur early during colorectal tumorigenesis.

Authors:  S M Powell; N Zilz; Y Beazer-Barclay; T M Bryan; S R Hamilton; S N Thibodeau; B Vogelstein; K W Kinzler
Journal:  Nature       Date:  1992-09-17       Impact factor: 49.962

9.  Mutations in APC, Kirsten-ras, and p53--alternative genetic pathways to colorectal cancer.

Authors:  Gillian Smith; Francis A Carey; Julie Beattie; Murray J V Wilkie; Tracy J Lightfoot; Jonathan Coxhead; R Colin Garner; Robert J C Steele; C Roland Wolf
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-01       Impact factor: 11.205

10.  Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas.

Authors:  B Dix; P Robbins; S Carrello; A House; B Iacopetta
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

View more
  17 in total

1.  K-ras genetic mutation and influencing factor analysis for Han and Uygur nationality colorectal cancer patients.

Authors:  Mayinur Eli; Ablikim Mollayup; Chao Liu; Chao Zheng; Yong-Xing Bao
Journal:  Int J Clin Exp Med       Date:  2015-06-15

2.  The prognostic value of elevated ezrin in patients with osteosarcoma.

Authors:  Deng-Xing Lun; Yong-Cheng Hu; Zhao-Wan Xu; Li-Na Xu; Bin-Wu Wang
Journal:  Tumour Biol       Date:  2013-09-07

3.  Prognostic effect of p53 expression in patients with completely resected colorectal cancer.

Authors:  Bin-Wei Liu; Yang Liu; Jun-Ru Liu; Zhong-Xu Feng; Tong Liu
Journal:  Tumour Biol       Date:  2014-07-04

4.  Molecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution pattern.

Authors:  Humaid O Al-Shamsi; Jeremy Jones; Yazan Fahmawi; Ibrahim Dahbour; Aziz Tabash; Reham Abdel-Wahab; Ahmed O S Abousamra; Kenna R Shaw; Lianchun Xiao; Manal M Hassan; Benjamin R Kipp; Scott Kopetz; Amr S Soliman; Robert R McWilliams; Robert A Wolff
Journal:  J Gastrointest Oncol       Date:  2016-12

5.  EphA4-mediated signaling regulates the aggressive phenotype of irradiation survivor colorectal cancer cells.

Authors:  Priscila Guimarães de Marcondes; Lilian Gonçalves Bastos; Julio Cesar Madureira de-Freitas-Junior; Murilo Ramos Rocha; José Andrés Morgado-Díaz
Journal:  Tumour Biol       Date:  2016-06-21

6.  Lack of association between interleukin-4 -524C>T polymorphism and colorectal cancer susceptibility.

Authors:  Huanlei Wu; Jia Hu; Bo Liu; Yu Tao; Xiao Zhou; Xianglin Yuan
Journal:  Tumour Biol       Date:  2013-12-07

7.  T7 Endonuclease I-mediated voltammetric detection of KRAS mutation coupled with horseradish peroxidase for signal amplification.

Authors:  Pinky Chowdhury; Byung Seok Cha; Seokjoon Kim; Eun Sung Lee; Taehwi Yoon; Jisu Woo; Ki Soo Park
Journal:  Mikrochim Acta       Date:  2022-01-27       Impact factor: 5.833

8.  Molecular spectrum of KRAS, BRAF, and PIK3CA gene mutation: determination of frequency, distribution pattern in Indian colorectal carcinoma.

Authors:  Swati Bisht; Firoz Ahmad; Satyakam Sawaimoon; Simi Bhatia; Bibhu Ranjan Das
Journal:  Med Oncol       Date:  2014-07-30       Impact factor: 3.064

9.  SMAD7 rs12953717 polymorphism contributes to increased risk of colorectal cancer.

Authors:  Yanliang Hu; Zhifang Sun; Anhua Zhang; Jinjie Zhang
Journal:  Tumour Biol       Date:  2013-08-16

10.  Prevalence of colorectal cancer biomarkers and their impact on clinical outcomes in Riyadh, Saudi Arabia.

Authors:  Amjad Alharbi; Haifa Bin Dokhi; Ghadir Almuhaini; Futoon Alomran; Emad Masuadi; Nouf Alomran
Journal:  PLoS One       Date:  2021-05-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.